Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Education
Published in: Journal of Cancer Education 1/2013

01-03-2013 | Reflection

Pumpkin Therapy

Author: Tina Gove Kebalka

Published in: Journal of Cancer Education | Issue 1/2013

Login to get access

Excerpt

Haven’t we all heard of music therapy? Art therapy? Group therapy? Or even pet therapy? What about “Pumpkin Therapy?” No, I am not talking about making pumpkin pies, cookies, or using the bright orange flesh as a new way to fight wrinkles. Our family has just witnessed one of the first (to my knowledge) research projects on “Pumpkin Therapy” conducted by my father, George Gove. …
Metadata
Title
Pumpkin Therapy
Author
Tina Gove Kebalka
Publication date
01-03-2013
Publisher
Springer-Verlag
Published in
Journal of Cancer Education / Issue 1/2013
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-013-0462-4

Other articles of this Issue 1/2013

Journal of Cancer Education 1/2013 Go to the issue

OriginalPaper

Testing Messages to Encourage Discussion of Clinical Trials Among Cancer Survivors and Their Physicians: Examining Monitoring Style and Message Detail

OriginalPaper

Moving the Agenda Forward for Cancer Patient Navigation: Understanding Volunteer and Peer Navigation Approaches

EditorialNotes

Teaching Equals Helping Students Learn

OriginalPaper

American Indian Perceptions of Colorectal Cancer Screening: Viewpoints from Adults Under Age 50

ReviewPaper

Evaluating Postgraduate Public Health and Biomedical Training Program Outcomes:

OriginalPaper

Evaluation of the Impact of NCI’s Summer Curriculum on Cancer Prevention on Participants from Low- and Middle-Income Countries
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits